TEVJF Stock | News | Quote | Stock Forum | Saturday, October

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Teva Pharmaceutical Industries Ltd. TEVJF Company Overview 

Stock Message Board http://investorshangout.com/search?q=TEVJF&am...mp;yt1=Go!

Last Updated: Saturday, October 12, 2013 11:19:40 PM

Teva Pharmaceutical Industries Ltd. TEVJF Current Price and Quotes
Last Price
Previous Close Open
Daily Range - 52wk Range -
Volume Dividend
Average Vol (3m) 193 Yield N/A
Teva Pharmaceutical Industries Ltd. TEVJF
Company Information

5 Basel Street, P.O. Box 3190
Petach Tikva 49131
Israel

Website: http://www.tevapharm.com
Phone: 972-3-926-7267

Teva Pharmaceutical Industries Ltd. TEVJF
Teva Pharmaceutical Industries Ltd. TEVJF
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Dec 31, 2012 20-F
CIK 0000818686
Fiscal Year End 12/31
OTC Marketplace Grey Market
Profile Data

SIC - Industry Classification 2819 - Industrial inorganic chemicals, misc
Incorporated In: Israel
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Israel Makov President, CEO
Dan Suesskind CFO
Company Directors

Not Available
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Teva Pharmaceutical Industries Ltd. TEVJF
TEVJF Security Details Other Company Securities

Share Structure

Market Value1 $36,776,255,175 a/o Oct 11, 2013
Shares Outstanding 941,773,500 a/o Dec 15, 2011
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record Not Available
Non US Stock Exchange Listing

TEVA - Tel Aviv Stock Exchange - Qualified
Short Selling Data

Short Interest 0 (-100%)
Aug 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)



Teva Pharmaceutical Industries Ltd. TEVJF Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 20,317,000 18,312,000 16,121,000 13,899,000
Cost of Revenue 9,665,000 8,797,000 7,056,000 6,532,000
Gross Profit 10,652,000 9,515,000 9,065,000 7,367,000
Operating Expenses

Research and Development 1,356,000 1,095,000 951,000 825,000
Sales, General and Admin. 5,117,000 4,410,000 3,833,000 3,499,000
Non-Recurring Items 1,974,000 901,000 410,000 638,000
Other - - - -
Operating Income 2,205,000 3,109,000 3,871,000 2,405,000
Income From Continuing Operations

Add'l Income/Expense Items - - - (202,000)
Earnings Before Interest and Tax 2,205,000 3,109,000 3,871,000 2,203,000
Interest Expense 386,000 153,000 225,000 -
Earnings Before Tax 1,819,000 2,956,000 3,646,000 2,203,000
Income Tax (137,000) 127,000 283,000 166,000
Minority Interest (53,000) 9,000 8,000 4,000
Equity Earnings Unconsolidated Subsidiary (46,000) (61,000) (24,000) (33,000)
Net Income Cont. Operations 1,963,000 2,759,000 3,331,000 2,000,000
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 1,963,000 2,759,000 3,331,000 2,000,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 1,963,000 2,759,000 3,331,000 2,000,000

Teva Pharmaceutical Industries Ltd. TEVJF Recent News

Oct 11, 2013 Generic giant Teva will trim 5,000 jobs
Oct 10, 2013 Teva to Report Third Quarter 2013 Financial Results on October 31, 2013
Oct 10, 2013 Teva to fire 5,000 employees worldwide
Oct 10, 2013 Globes, Tel Aviv, Israel, Shiri Habib-Valdhorn and Gali Weinreb column
Oct 10, 2013 Teva Accelerates Cost Reduction Program
Oct 6, 2013 BRIEF: Dutch court upholds Teva's Copaxone patent
Oct 4, 2013 New Data Presented at 29th ECTRIMS Congress Reinforce the Clinical Profile of Investigational Laquinimod on Disease Progression and Inflammation in Relapsing-Remitting Multiple Sclerosis
Oct 3, 2013 Intel Israel president: I hate 'Start-up Nation'
Oct 3, 2013 Teva Announces Favorable Ruling on COPAXONE Patent Litigation in the Netherlands
Oct 3, 2013 Teva to Present Further Results of Twenty-Year Open-Label Extension Study of Glatiramer Acetate 20 mg Daily for Relapsing-Remitting Multiple Sclerosis

1
2
3
4
5
6
7
8
next >
last >>

TEVJF Teva Pharmaceutical Industries Ltd. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=TEVJF&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/TEVJF/quote
Stock Chart http://www.otcmarkets.com/stock/TEVJF/chart
Company Info http://www.otcmarkets.com/stock/TEVJF/company-info
Recent News http://www.otcmarkets.com/stock/TEVJF/news
Financials http://www.otcmarkets.com/stock/TEVJF/financials
Filings and Disclosure http://www.otcmarkets.com/stock/TEVJF/filings
Short Sales http://www.otcmarkets.com/stock/TEVJF/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/TEVJF/insider-transactions
Research Reports http://www.otcmarkets.com/stock/TEVJF/research
Summary http://finance.yahoo.com/q?s=TEVJF
Historical Prices http://finance.yahoo.com/q/hp?s=TEVJF+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=TEVJF
Basic Chart http://finance.yahoo.com/q/bc?s=TEVJF+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=TEVJF+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=TEVJF+Headlines
Press Releases http://finance.yahoo.com/q/p?s=TEVJF+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=TEVJF+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=TEVJF+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=TEVJF+Industry
Major Holders http://finance.yahoo.com/q/mh?s=TEVJF+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=TEVJF+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=TEVJF+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=TEVJF
Balance Sheet http://finance.yahoo.com/q/bs?s=TEVJF
Cash Flow http://finance.yahoo.com/q/cf?s=TEVJF+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/TEVJF
Market Watch http://www.marketwatch.com/investing/stock/TEVJF
Bloomberg http://www.bloomberg.com/quote/TEVJF:US
Morningstar http://quotes.morningstar.com/stock/s?t=TEVJF
Bussinessweek http://investing.businessweek.com/research/st...cker=TEVJF
Barchart http://www.barchart.com/quotes/stocks/TEVJF
OTC Short Report http://otcshortreport.com/index.php?index=TEVJF
Investopedia http://www.investopedia.com/markets/stocks/TEVJF/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 86

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull

Updated Category News Views 70

Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...

Continue Reading
Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 78

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
Gaotu Techedu's Q3 Results: A Look at AI-Driven Growth

Updated Category News Views 11

Gaotu Techedu to Unveil Q3 Results Mark your calendars, folks—Gaotu Techedu Inc. (NYSE: GOTU) is gearing up to dish out its third quarter financial results on November 25, 2026. As usual, these numbers will slide out before the U.S. markets spring into action. It's one of those moments when investors like us strap in and watch for any movement that might toss our...

Continue Reading
Horizon Capital Hits €200M for Ukraine Resilience

Updated Category News Views 30

An Unprecedented Leap Amidst Uncertainty Right in the middle of rebuilding a nation, Horizon Capital's Catalyst Fund has managed to tap into a well of optimism—or guts, depending on how you look at it. With €200 million already in its pocket out of a €300 million goal, this private equity powerhouse is taking a calculated gamble on Ukraine's economic resilience and...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 165

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 121

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 39

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 275

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

Matt Hougan Shares Insights on Bitcoin's Potential Surge

Updated Category News Views 165

Understanding Bitcoin's Growth Potential Matt Hougan, the Chief Investment Officer at Bitwise, sheds light on the driving forces behind the burgeoning interest in Bitcoin. He emphasizes concerns over the decline of fiat currencies and noteworthy inflows into Bitcoin ETFs as the catalysts propelling Bitcoin's journey towards new heights. This surge towards potential record...

Continue Reading
Empowering Futures: Access Bank's Commitment to Education

Updated Category News Views 174

Support for Educational Development In recent years, The Access Bank UK Ltd has made significant strides in supporting educational initiatives aimed at transforming lives. This commitment is exemplified by the annual Polo Cup event that they host in collaboration with UNICEF and Fifth Chukker. The Access Bank Cup has become more than just a sporting affair; it is a beacon...

Continue Reading
Gary Brecka's Event Redefines Longevity's Future in L.A.

Updated Category News Views 46

Exploring Longevity: A Day Like No Other Alright, picture this: a convergence of wellness diehards, human performance buffs, and curious minds, all filing into the Peacock Theater in Los Angeles. It's August 16th and they're here for Gary Brecka LIVE. This is no run-of-the-mill wellness seminar; it's an exclusive deep dive into the world of longevity hosted by Sequel...

Continue Reading
Ultragenyx Pharmaceutical and Others Face Challenges in Ratings

Updated Category News Views 164

Stock Market Overview This morning, U.S. stock futures indicated a downward trend, with the Dow futures decreasing by about 100 points. Given the numerous fluctuations in the market recently, this drop is indicative of the challenges many companies are facing. Ultragenyx Pharmaceutical Inc Performance Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have sharply...

Continue Reading
Netflix's Future: Overcoming Slower Subscriber Growth Strategies

Updated Category News Views 185

Analyzing Netflix's Subscription Growth and Future Strategies Netflix, a leading name in streaming services, is facing a potential slowdown in subscriber additions. Analysts suggest that the streaming giant might experience its most modest subscriber growth in the past six quarters as the gains from its recent password-sharing crackdown start to wane. With this shifting...

Continue Reading